AbCellera Biologics
ABCL
ABCL
86 hedge funds and large institutions have $2.42B invested in AbCellera Biologics in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.16% more ownership
Funds ownership: 25.65% → 26.81% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
12% less capital invested
Capital invested by funds: $2.74B → $2.42B (-$324M)
Holders
86
Holding in Top 10
5
Calls
$2.35M
Puts
$1.42M
Top Buyers
| 1 | +$77.1M | |
| 2 | +$39.2M | |
| 3 | +$35.7M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$35.6M |
| 5 |
Swedbank
Stockholm,
Sweden
|
+$19.8M |
Top Sellers
| 1 | -$46.8M | |
| 2 | -$24.1M | |
| 3 | -$20.1M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$18.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$15.7M |